Race against time: new drug combo aims to slash sepsis deaths in africa
NCT ID NCT07332325
Summary
This study aims to improve survival for adults with HIV who develop life-threatening sepsis in sub-Saharan Africa. Researchers are testing whether adding a steroid (hydrocortisone) and a stronger combination of antibiotics to the current standard treatment helps more people survive the first 28 days. The trial will enroll 344 hospitalized patients to see if this new approach can become a better standard of care for this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fort Portal Regional Referral Hospital
Fort Portal, Uganda
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kibong'oto Infectious Diseases Hospital
Sanya Juu, Tanzania
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mbarara Regional Referral Hospital
Mbarara, Uganda
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sekou Toure Regional Referral Hospital
Mwanza, Tanzania
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.